BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 3487779)

  • 1. Pediatric diphtheria and tetanus toxoids-adsorbed vaccine: immune response to the first booster following the diphtheria and tetanus toxoids vaccine primary series.
    Pichichero ME; Barkin RM; Samuelson JS
    Pediatr Infect Dis; 1986; 5(4):428-30. PubMed ID: 3487779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acellular pertussis vaccine: immunogenicity and safety of an acellular pertussis vs. a whole cell pertussis vaccine combined with diphtheria and tetanus toxoids as a booster in 18- to 24-month old children.
    Pichichero ME; Badgett JT; Rodgers GC; McLinn S; Trevino-Scatterday B; Nelson JD
    Pediatr Infect Dis J; 1987 Apr; 6(4):352-63. PubMed ID: 3495775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary immunization with diphtheria-tetanus toxoids vaccine and diphtheria-tetanus toxoids-pertussis vaccine adsorbed: comparison of schedules.
    Barkin RM; Samuelson JS; Gotlin LP; Barkin SZ
    Pediatr Infect Dis; 1985; 4(2):168-71. PubMed ID: 3885180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative immunologic effectiveness of variants of the DTP vaccine].
    Baeva EA; Selezneva TS; Rezepov FF; Chebotareva SV; El'nitskaia EA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Oct; (10):50-2. PubMed ID: 2879402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparative evaluation of the immunological efficacy of ADPT vaccine and ADT-M anatoxin in the immunization of children against diphtheria and tetanus].
    Rusakova EV; Bezuglova MS; Vasil'eva VI; Frank KD; Panina GM
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jul; (7):52-5. PubMed ID: 1950266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diphtheria and tetanus toxoids and pertussis vaccine adsorbed (DTP): response to varying immunizing dosage and schedule.
    Barkin RM; Samuelson JS; Gotlin LP
    Dev Biol Stand; 1985; 61():297-307. PubMed ID: 2872117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative reactogenicity and immunogenicity of booster doses of diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine and diphtheria-tetanus-inactivated poliovirus vaccine in preadolescents.
    Bégué PC; Grimprel EM; Giovannangeli MD; Abitbol VI
    Pediatr Infect Dis J; 1998 Sep; 17(9):804-9. PubMed ID: 9779766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the immunoglobulins and specific antibodies in the blood of rabbits immunized with ADTP vaccine and ADT-anatoxin with normal and reduced antigen contents].
    Kozlova NN; Gervazieva VB; Il'nitskaia EA; Moshiashvili IIa
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr; (4):39-42. PubMed ID: 3874505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines.
    Mark A; Björkstén B; Granström M
    Vaccine; 1995 May; 13(7):669-73. PubMed ID: 7668036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diphtheria, tetanus and pertussis antibodies in 10-year-old children before and after a booster dose of three toxoids: implications for the timing of a booster dose.
    Trollfors B; Knutsson N; Taranger J; Mark A; Bergfors E; Sundh V; Lagergård T
    Eur J Pediatr; 2006 Jan; 165(1):14-8. PubMed ID: 16249929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
    Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R
    J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.
    Pichichero ME; Blatter MM; Kennedy WA; Hedrick J; Descamps D; Friedland LR
    Pediatrics; 2006 Apr; 117(4):1084-93. PubMed ID: 16585302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum antibodies to diphtheria-tetanus-pertussis vaccine components in Argentine children.
    Pasetti M; Eriksson P; Ferrero F; Manghi M
    Infection; 1997; 25(6):339-45. PubMed ID: 9427051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced immunogenicity of diphtheria and tetanus toxoids when combined with pertussis toxoid.
    Trollfors B; Taranger J; Lagergård T; Sundh V
    Pediatr Infect Dis J; 2005 Jan; 24(1):85-6. PubMed ID: 15665717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibody response to the fractionated administration of the 2d or 3d basic vaccination injection with a mixed vaccine against diphtheria, tetanus and pertussis].
    Vodicková M; Svandová E
    Cesk Pediatr; 1986 Jun; 41(6):321-3. PubMed ID: 2872973
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunological effectiveness of secondary revaccination against tetanus performed at prolonged intervals].
    Maksimova NM; Basova NN; Sukhorukova NL; Finkel' MP
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jun; (6):43-6. PubMed ID: 3307239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Half-dose immunization for diphtheria, tetanus, pertussis: response of preterm infants.
    Bernbaum J; Daft A; Samuelson J; Polin RA
    Pediatrics; 1989 Apr; 83(4):471-6. PubMed ID: 2538797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.
    Bernstein HH; Rothstein EP; Reisinger KS; Blatter MM; Arbeter AM; Fontana ME; Jacobs JM; Long SS; Rathfon H; Crayne O
    Pediatrics; 1994 Apr; 93(4):656-9. PubMed ID: 8134224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.
    Larnaudie S; Guiso N; Baptiste C; Desaint C; Desforges L; Lebon P; Soubeyrand B; Launay O
    Hum Vaccin; 2010 Oct; 6(10):829-34. PubMed ID: 20864810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of infants to Haemophilus influenzae type b polysaccharide and diphtheria-tetanus-pertussis vaccines in combination.
    Lepow ML; Peter G; Glode MP; Daum RS; Calnen G; Knight KM; Mayer D; Kuo JS; Lui NS
    J Infect Dis; 1984 Jun; 149(6):950-5. PubMed ID: 6376656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.